203 filings
Page 2 of 11
8-K
ks48ee9
14 Aug 23
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
5:25pm
8-K
ofk7e
10 Aug 23
Entry into a Material Definitive Agreement
5:29pm
8-K
tqj9bd2ja504
17 Jul 23
Material Modifications to Rights of Security Holders
4:05pm
8-K
81r ugyy6xd67070qj
10 Jul 23
Entry into a Material Definitive Agreement
5:16pm
8-K
xs878jke
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
kzuus8md0w8 6wnli1
16 Jun 23
Evofem Biosciences Announces Financial Results for the First Quarter of 2023
4:01pm
8-K
nddi9fy5qv3
1 Jun 23
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
8:36am
8-K
s1epe4gs6c2nxmi
17 May 23
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
5:13pm
8-K
b8do9ro3 egtgwflm3c4
5 May 23
Other Events
5:00pm
8-K
dc7hxbbxu5 s6ya
28 Apr 23
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
6:50am
8-K
nd97h4gr
14 Apr 23
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
9:05am
8-K/A
14gfu
11 Apr 23
Entry into a Material Definitive Agreement
8:17pm
8-K
rm07iwg8hwzwhtjgp0t
10 Apr 23
Entry into a Material Definitive Agreement
5:26pm
8-K
u1mw963i36
24 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
prdftaea0d23z
20 Mar 23
Evofem Biosciences Announces Cost Reduction Measures
9:55pm
8-K
pqz8iz9765fqp
16 Mar 23
Submission of Matters to a Vote of Security Holders
7:07pm
8-K
vtig0ywgfudq2
14 Mar 23
Entry into a Material Definitive Agreement
9:00am
8-K
v3awow
10 Mar 23
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:27pm
8-K
vmm8w2b5te6rb96p
9 Mar 23
Evofem Biosciences Appoints Interim Chief Financial Officer
4:01pm
8-K
43qlj9ose8zvw42 un8
23 Feb 23
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
8:59pm